Patent · US Active

Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases

US10100307B2 · kind B2 · utility

6Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 30, 2015
Grant dateOct 16, 2018
Priority date
Expiry dateOct 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/00011
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of a reverse-transcriptase inhibitor in the prevention or treatment of a degenerative disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.